Patent details

Basic Information

Publication number:

EP2506868

PCT Application Number:

US2010059136

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP108352550

PCT Publication Number:

WO2011069164

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF

French Title of Invention:

POLYPEPTIDES CHIMÉRIQUES ET HYBRIDES DE FACTEUR VIII-FC, ET PROCÉDÉS D'UTILISATION DE CEUX-CI

German Title of Invention:

CHIMÄRE UND HYBRIDE FAKTOR-VIII-FC-POLYPEPTIDE UND VERFAHREN ZU IHRER ANWENDUNG

SPC Number:

Dates

Filing date:

06/12/2010

Grant date:

15/11/2017

EP Publication Date:

10/10/2012

PCT Publication Date:

09/06/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/11/2017

EP B1 Publication Date:

15/11/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/12/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/11/2017

 

 

Name:

Bioverativ Therapeutics Inc.

Address:

225 Second Avenue, Waltham, MA 02451, United States (US)

Agent

Name:

STOLMÁR & PARTNER

From:

25/01/2018

Address:

BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)

To:

Inventor

1

Name:

PIERCE, Glenn

Address:

United States (US)

2

Name:

PETERS, Robert

Address:

United States (US)

3

Name:

SOMMER, Jurg

Address:

United States (US)

4

Name:

MCKINNEY, Byron

Address:

United States (US)

5

Name:

BITONTI, Alan, J.

Address:

United States (US)

6

Name:

DUMONT, Jennifer, A.

Address:

United States (US)

7

Name:

JIANG, Haiyan

Address:

United States (US)

8

Name:

OTTMER, Matt

Address:

United States (US)

9

Name:

LUK, Alvin

Address:

United States (US)

10

Name:

LOW, Susan

Address:

United States (US)

11

Name:

NUGENT, Karen

Address:

United Kingdom (GB)

12

Name:

LI, Lian

Address:

United States (US)

Priority

1

Priority Number:

267070 P

Priority Date:

06/12/2009

Priority Country:

United States (US)

2

Priority Number:

285054 P

Priority Date:

09/12/2009

Priority Country:

United States (US)

3

Priority Number:

301592 P

Priority Date:

04/02/2010

Priority Country:

United States (US)

4

Priority Number:

363065 P

Priority Date:

09/07/2010

Priority Country:

United States (US)

5

Priority Number:

373113 P

Priority Date:

12/08/2010

Priority Country:

United States (US)

6

Priority Number:

410929 P

Priority Date:

07/11/2010

Priority Country:

United States (US)

7

Priority Number:

419676 P

Priority Date:

03/12/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/37; A61P 7/04; C07K 14/755; C07K 16/46;

Publication

European Patent Bulletin

1

Issue number:

201746

Publication date:

15/11/2017

Description:

Grant (B1)

2

Issue number:

202117

Publication date:

28/04/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:

202115

Publication date:

14/04/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/12/2025

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

28/11/2024

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
08/02/2018	Outgoing Correspondence	1
25/01/2018	Power Of Attorney	2